Another interesting thought, speaking of the mono
Post# of 148300
(Total Views: 332)
Posted On: 09/06/2019 5:26:02 PM
Another interesting thought, speaking of the mono trial of Dolutegravir by ViiV.
NP said last year ViiV wanted to partner with leronlimab with 2 drug once a week combo last year. This is the same ViiV that is working with J&J on monthly injections with a 2 drug combo cabotegravir and rilpivirine. And also the company that got the first 2 drug combo dolutegravir and lamivudine approved this year. Gilead better watch out, or they are going to get run over, it seems they have the obvious solution right in front of them... we will see in time. all,imo.
NP said last year ViiV wanted to partner with leronlimab with 2 drug once a week combo last year. This is the same ViiV that is working with J&J on monthly injections with a 2 drug combo cabotegravir and rilpivirine. And also the company that got the first 2 drug combo dolutegravir and lamivudine approved this year. Gilead better watch out, or they are going to get run over, it seems they have the obvious solution right in front of them... we will see in time. all,imo.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼